Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis.
Miura N, Mori K, Mostafaei H, Quhal F, Sari Motlagh R, Abufaraj M, Pradere B, Aydh A, Laukhtina E, D'Andrea D, Saika T, Shariat SF. Miura N, et al. Among authors: sari motlagh r. Int J Clin Oncol. 2020 Nov;25(11):1881-1891. doi: 10.1007/s10147-020-01747-1. Epub 2020 Jul 17. Int J Clin Oncol. 2020. PMID: 32681382 Free PMC article.
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
Schuettfort VM, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF. Schuettfort VM, et al. Among authors: sari motlagh r. BJU Int. 2022 Feb;129(2):182-193. doi: 10.1111/bju.15379. Epub 2021 Apr 7. BJU Int. 2022. PMID: 33650265 Free PMC article. Clinical Trial.
Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials.
Sari Motlagh R, Mori K, Laukhtina E, Aydh A, Katayama S, Grossmann NC, Mostafai H, Pradere B, Quhal F, Schuettfort VM, Roshandel MR, Karakiewicz PI, Teoh J, Shariat SF, Fajkovic H. Sari Motlagh R, et al. BJU Int. 2021 Sep;128(3):280-289. doi: 10.1111/bju.15383. Epub 2021 May 3. BJU Int. 2021. PMID: 33683778 Free PMC article.
Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis.
Mori K, Mostafaei H, Sari Motlagh R, Pradere B, Quhal F, Laukhtina E, Schuettfort VM, Kramer G, Abufaraj M, Karakiewicz PI, Kimura T, Egawa S, Shariat SF. Mori K, et al. Among authors: sari motlagh r. BJU Int. 2022 Apr;129(4):423-433. doi: 10.1111/bju.15507. Epub 2021 Jul 21. BJU Int. 2022. PMID: 34171173 Free PMC article. Review.
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis.
Yanagisawa T, Mori K, Quhal F, Kawada T, Mostafaei H, Laukhtina E, Rajwa P, Sari Motlagh R, Aydh A, König F, Pallauf M, Pradere B, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Among authors: sari motlagh r. BJU Int. 2023 May;131(5):540-552. doi: 10.1111/bju.15913. Epub 2022 Oct 18. BJU Int. 2023. PMID: 36196670 Review.
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis.
Kawada T, Yanagisawa T, Mostafaei H, Sari Motlagh R, Quhal F, Rajwa P, Laukhtina E, von Deimling M, Bianchi A, Majdoub M, Pallauf M, Pradere B, Teoh JY, Karakiewicz PI, Araki M, Shariat SF. Kawada T, et al. Among authors: sari motlagh r. Eur Urol Focus. 2023 Mar;9(2):264-274. doi: 10.1016/j.euf.2023.01.019. Epub 2023 Feb 9. Eur Urol Focus. 2023. PMID: 36774273 Review.
Role of pelvic drain and timing of urethral catheter removal following RARP: a systematic review and meta-analysis.
Yanagisawa T, Kawada T, Mostafaei H, Sari Motlagh R, Quhal F, Laukhtina E, Rajwa P, von Deimling M, Bianchi A, Pallauf M, Pradere B, Karakiewicz PI, Miki J, Kimura T, Shariat SF. Yanagisawa T, et al. Among authors: sari motlagh r. BJU Int. 2023 Aug;132(2):132-145. doi: 10.1111/bju.16022. Epub 2023 Apr 20. BJU Int. 2023. PMID: 37014288 Review.
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.
Mori K, Miura N, Mostafaei H, Quhal F, Sari Motlagh R, Pradere B, Kimura S, Kimura T, Egawa S, Briganti A, Karakiewicz PI, Shariat SF. Mori K, et al. Among authors: sari motlagh r. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):539-548. doi: 10.1038/s41391-020-0222-6. Epub 2020 Mar 9. Prostate Cancer Prostatic Dis. 2020. PMID: 32152435
66 results